Director - DMPK
Repare Therapeutics
Saint-Laurent, Quebec, Canada
Robert Papp is currently the Director of the DMPK group at Repare Therapeutics and focuses on discovering, selecting and bringing forward clinical candidates for targeted cancer therapies across numerous projects. Robert’s 20+ year career has spanned many aspects of small molecule research in both discovery and development. Upon completion of undergraduate studies at McGill University and an MSc in Chemistry from Concordia University, he began his career at Merck Frosst Canada in Pharmaceutical Sciences and DMPK. This was followed by similar roles at AstraZeneca and Vertex Pharmaceuticals, with positions of increasing responsibilities. His main interest lies at the interface between DMPK, medicinal chemistry and formulation sciences.
Disclosure information not submitted.
Wednesday, October 19, 2022
9:30 AM – 10:00 AM ET